KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Amgen (AMGN) over the last 17 years, with Q4 2025 value amounting to -$693.0 million.

  • Amgen's Cash from Investing Activities fell 7238.81% to -$693.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$1.9 billion, marking a year-over-year decrease of 8575.53%. This contributed to the annual value of -$1.9 billion for FY2025, which is 8575.53% down from last year.
  • Amgen's Cash from Investing Activities amounted to -$693.0 million in Q4 2025, which was down 7238.81% from -$414.0 million recorded in Q3 2025.
  • Over the past 5 years, Amgen's Cash from Investing Activities peaked at $1.4 billion during Q1 2023, and registered a low of -$27.1 billion during Q4 2023.
  • Moreover, its 5-year median value for Cash from Investing Activities was -$264.5 million (2022), whereas its average is -$1.7 billion.
  • Per our database at Business Quant, Amgen's Cash from Investing Activities crashed by 141000.0% in 2022 and then soared by 132342.34% in 2023.
  • Quarter analysis of 5 years shows Amgen's Cash from Investing Activities stood at -$230.0 million in 2021, then plummeted by 1410.0% to -$3.5 billion in 2022, then tumbled by 679.99% to -$27.1 billion in 2023, then skyrocketed by 98.52% to -$402.0 million in 2024, then plummeted by 72.39% to -$693.0 million in 2025.
  • Its last three reported values are -$693.0 million in Q4 2025, -$414.0 million for Q3 2025, and -$389.0 million during Q2 2025.